DK2285357T3 - Farmaceutisk sammensætning omfattende brivaracetam - Google Patents
Farmaceutisk sammensætning omfattende brivaracetamInfo
- Publication number
- DK2285357T3 DK2285357T3 DK09753941.5T DK09753941T DK2285357T3 DK 2285357 T3 DK2285357 T3 DK 2285357T3 DK 09753941 T DK09753941 T DK 09753941T DK 2285357 T3 DK2285357 T3 DK 2285357T3
- Authority
- DK
- Denmark
- Prior art keywords
- brivaracetam
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- MSYKRHVOOPPJKU-BDAKNGLRSA-N brivaracetam Chemical compound CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1 MSYKRHVOOPPJKU-BDAKNGLRSA-N 0.000 title 1
- 229960002161 brivaracetam Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08009919 | 2008-05-30 | ||
| PCT/EP2009/056570 WO2009144286A1 (en) | 2008-05-30 | 2009-05-28 | Pharmaceutical compositions comprising brivaracetam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2285357T3 true DK2285357T3 (da) | 2014-06-02 |
Family
ID=39714168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09753941.5T DK2285357T3 (da) | 2008-05-30 | 2009-05-28 | Farmaceutisk sammensætning omfattende brivaracetam |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8435564B2 (da) |
| EP (1) | EP2285357B8 (da) |
| JP (1) | JP5553452B2 (da) |
| CN (1) | CN102046153B (da) |
| BR (1) | BRPI0912161A2 (da) |
| CA (1) | CA2722093C (da) |
| DK (1) | DK2285357T3 (da) |
| ES (1) | ES2465478T3 (da) |
| PL (1) | PL2285357T3 (da) |
| WO (1) | WO2009144286A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2563339A1 (en) | 2010-04-29 | 2013-03-06 | Lupin Limited | Controlled release pharmaceutical compositions of brivaracetam |
| EP2618827B1 (en) * | 2010-09-21 | 2021-06-02 | Intekrin Therapeutics, Inc. | Antidiabetic solid pharmaceutical compositions |
| EP3397253A1 (en) | 2015-12-30 | 2018-11-07 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of seizure-related disorders |
| WO2018224680A1 (en) * | 2017-06-09 | 2018-12-13 | Bimeda Research & Development Limited | Intramammary veterinary composition |
| JP7335870B2 (ja) * | 2017-08-31 | 2023-08-30 | パーデュー、ファーマ、リミテッド、パートナーシップ | 医薬剤形 |
| CN109833300A (zh) * | 2017-11-28 | 2019-06-04 | 浙江京新药业股份有限公司 | 一种抗癫痫药物口服组合物及其制备方法 |
| CN110638743B (zh) * | 2019-10-25 | 2023-03-28 | 乐普制药科技有限公司 | 一种含布立西坦的组合物 |
| CN111407738A (zh) * | 2020-04-03 | 2020-07-14 | 江苏艾立康药业股份有限公司 | 一种布立西坦控释制剂及其制备方法 |
| CN118267385A (zh) * | 2020-07-09 | 2024-07-02 | 上海云晟研新生物科技有限公司 | 一种布瓦西坦药物组合物、其制备方法及应用 |
| WO2022193723A1 (zh) * | 2021-03-17 | 2022-09-22 | 长沙晶易医药科技有限公司 | 一种组合物及其制备方法和用途 |
| CN115192572B (zh) * | 2021-04-08 | 2023-09-19 | 成都同道慧宜生物医药科技有限公司 | 布立西坦药剂、其制备方法和应用 |
| CN115721624A (zh) * | 2021-08-25 | 2023-03-03 | 北京海美源医药科技有限公司 | 一种布立西坦药物组合物及其制备方法和其应用 |
| US12133918B2 (en) | 2021-10-01 | 2024-11-05 | Griffin Gamma, Llc | Partially pre-gelatinized cassava starch as pharmaceutical excipient |
| TWI918738B (zh) | 2021-10-14 | 2026-03-21 | 大陸商上海雲晟研新生物科技股份有限公司 | 布瓦西坦藥物組合物、其製備方法及應用 |
| WO2023125348A1 (zh) * | 2021-12-27 | 2023-07-06 | 广东东阳光药业有限公司 | 布立西坦片剂及其制备方法 |
| CN118416004A (zh) | 2023-02-02 | 2024-08-02 | 泰州越洋医药开发有限公司 | 一种布立西坦双释三层片及其制备方法 |
| EP4491177A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | Film coated tablets of brivaracetam |
| EP4491176A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | A film coated tablet comprising brivaracetam |
| EP4559457A1 (en) * | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet composition of brivaracetam |
| EP4559456A1 (en) * | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet of brivaracetam |
| TR2023015501A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet |
| TR2023015500A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet kompozi̇syonu |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| EP1769092A4 (en) | 2004-06-29 | 2008-08-06 | Europ Nickel Plc | IMPROVED LIXIVIATION OF BASE METALS |
| AU2005325930B2 (en) * | 2005-01-27 | 2012-01-19 | Alembic Limited | Extended release formulation of Levetiracetam |
| WO2006090275A1 (en) * | 2005-02-24 | 2006-08-31 | Pfizer Limited | Treatment of incontinence |
| ATE498358T1 (de) | 2005-06-29 | 2011-03-15 | Compumedics Ltd | Sensoranordnung mit leitfähiger brücke |
| TW200735878A (en) * | 2005-11-18 | 2007-10-01 | Astrazeneca Ab | Pharmaceutical compositions |
| PL1954241T3 (pl) * | 2005-11-28 | 2013-03-29 | Orexigen Therapeutics Inc | Formulacja zonisamidu o przedłużonym uwalnianiu |
| US8338621B2 (en) * | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
| CA2635949A1 (en) * | 2006-01-11 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Controlled release formulation of divalproic acid and its derivatives |
| EP2041084B1 (en) * | 2006-06-08 | 2013-11-06 | UCB Pharma, S.A. | Co-crystals of pyrrolidinones |
| JP2006335771A (ja) * | 2006-09-22 | 2006-12-14 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
| EP2081563A1 (en) * | 2006-10-12 | 2009-07-29 | Abbott Laboratories | Pharmaceutical formulations |
-
2009
- 2009-05-28 EP EP09753941.5A patent/EP2285357B8/en not_active Revoked
- 2009-05-28 JP JP2011511013A patent/JP5553452B2/ja active Active
- 2009-05-28 PL PL09753941T patent/PL2285357T3/pl unknown
- 2009-05-28 BR BRPI0912161A patent/BRPI0912161A2/pt not_active IP Right Cessation
- 2009-05-28 US US12/993,704 patent/US8435564B2/en active Active
- 2009-05-28 CA CA2722093A patent/CA2722093C/en active Active
- 2009-05-28 ES ES09753941.5T patent/ES2465478T3/es active Active
- 2009-05-28 DK DK09753941.5T patent/DK2285357T3/da active
- 2009-05-28 WO PCT/EP2009/056570 patent/WO2009144286A1/en not_active Ceased
- 2009-05-28 CN CN200980120221.XA patent/CN102046153B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20110091547A1 (en) | 2011-04-21 |
| CN102046153B (zh) | 2015-06-17 |
| PL2285357T3 (pl) | 2014-08-29 |
| JP5553452B2 (ja) | 2014-07-16 |
| US8435564B2 (en) | 2013-05-07 |
| EP2285357B1 (en) | 2014-05-07 |
| ES2465478T3 (es) | 2014-06-05 |
| CN102046153A (zh) | 2011-05-04 |
| WO2009144286A1 (en) | 2009-12-03 |
| EP2285357B8 (en) | 2014-07-23 |
| ES2465478T8 (es) | 2014-08-22 |
| HK1153141A1 (en) | 2012-03-23 |
| CA2722093A1 (en) | 2009-12-03 |
| BRPI0912161A2 (pt) | 2015-10-06 |
| JP2011521927A (ja) | 2011-07-28 |
| CA2722093C (en) | 2015-04-28 |
| EP2285357A1 (en) | 2011-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| ES2465478T8 (es) | Composiciones farmacéuticas que comprenden brivaracetam | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| SMT201600259B (it) | Composizioni farmaceutiche antibatteriche | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| RU2493831C3 (ru) | Фармацевтические композиции | |
| BRPI0715712A2 (pt) | Composição farmacêutica | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| BR112012012108A2 (pt) | composição farmacêutica compreendendo propofol | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| DK2966175T3 (da) | Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| DK2391351T3 (da) | Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater | |
| PT2209464E (pt) | Composição farmacêutica antimalárica |